OrbiMed Capital GP V LLC — SEC Form 4 filings
SEC reporting owner CIK 1615374. 7 Form 4 filings on record with FilingPulse; latest filed 2026-04-09.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-26 to 2026-04-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 2 filings — 8,125,000 shares, $12,500,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 2,780,990 shares, $7,986,741 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 1,176,332 shares @ $4.16 ($4,891,894) in Corvus Pharmaceuticals, Inc., filed 2025-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | 10% owner | 3 | 5 legs · 8,125,000 sh · $12,500,000 | 4 legs · 104,658 sh · $674,847 | — |
| Corvus Pharmaceuticals, Inc. (CRVS) | Director, 10% owner | 2 | — | 1 leg · 1,176,332 sh · $4,891,894 | 4 |
| PMV Pharmaceuticals, Inc. (PMVP) | 10% owner | 2 | — | 2 legs · 1,500,000 sh · $2,420,000 | — |
Form 4 filings — OrbiMed Capital GP V LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-09 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52 | EDGAR |
| 2025-10-27 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with ORBIMED ADVISORS LLC | Sale (S): 1,000,000 @ $1.52 | EDGAR |
| 2025-10-10 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1 | EDGAR |
| 2025-09-12 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with ORBIMED ADVISORS LLC | Sale (S): 500,000 @ $1.80 | EDGAR |
| 2025-07-01 | 4 | Corvus Pharmaceuticals, Inc. (CRVS) jointly with ORBIMED ADVISORS LLC | Option exercise/expiry (X): 1,397,684 @ $3.50 · Sale (S): 1,176,332 @ $4.16 · Option exercise/expiry (X): 1,397,684 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | Corvus Pharmaceuticals, Inc. (CRVS) jointly with ORBIMED ADVISORS LLC | Purchase (P): 1,444,085 (derivative) @ $1.73 · Purchase (P): 1,397,684 (derivative) | EDGAR |
| 2024-01-26 | 4 | Adicet Bio, Inc. (ACET) jointly with ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership | Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1615374 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →